LEUKEMIA

医学 血液学

  • 影响指数:12.87
  • 中科院分区:医学 1区[Top]
  • 审稿周期:平均1月
  • 自引率:15.3%
  • 录取率:25.%
  • ISSN:2190-572X
  • 发刊频率:暂无数据
  • 年文章数:454
  • 国人占比:7.19%
  • 期刊网址:点击查看
  • 研究方向:白血病药物;机理
  • 期刊攻略
  • IF变化趋势
  • 期刊占比
  • 最新文章

期刊简介

3 BIOTECH杂志暂不明确行业,暂不明确子行业的级别不明杂志

收稿要求

暂无数据

建议

杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

DOI:10.1038/s41375-022-01620-2

发表时间:2022 Jul

作者:Alaggio R;Amador C;Anagnostopoulos I;Attygalle AD;Araujo IBO;Berti E;Bhagat G;Borges AM;Boyer D;Calaminici M;Chadburn A;Chan JKC;Cheuk W;Chng WJ;Choi JK;Chuang SS;Coupland SE;Czader M;Dave SS;de Jong D;Du MQ;Elenitoba-Johnson KS;Ferry J;Geyer J;Gratzinger D;Guitart J;Gujral S;Harris M;Harrison CJ;Hartmann S;Hochhaus A;Jansen PM;Karube K;Kempf W;Khoury J;Kimura H;Klapper W;Kovach AE;Kumar S;Lazar AJ;Lazzi S;Leoncini L;Leung N;Leventaki V;Li XQ;Lim MS;Liu WP;Louissaint A Jr;Marcogliese A;Medeiros LJ;Michal M;Miranda RN;Mitteldorf C;Montes-Moreno S;Morice W;Nardi V;Naresh KN;Natkunam Y;Ng SB;Oschlies I;Ott G;Parrens M;Pulitzer M;Rajkumar SV;Rawstron AC;Rech K;Rosenwald A;Said J;Sarkozy C;Sayed S;Saygin C;Schuh A;Sewell W;Siebert R;Sohani AR;Tooze R;Traverse-Glehen A;Vega F;Vergier B;Wechalekar AD;Wood B;Xerri L;Xiao W

The WHO Classification of Haematolymphoid Tumours.

DOI:10.1038/s41375-022-01625-x

发表时间:2022 Jul

作者:Cree IA

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

DOI:10.1038/s41375-022-01613-1

发表时间:2022 Jul

作者:Khoury JD;Solary E;Abla O;Akkari Y;Alaggio R;Apperley JF;Bejar R;Berti E;Busque L;Chan JKC;Chen W;Chen X;Chng WJ;Choi JK;Colmenero I;Coupland SE;Cross NCP;De Jong D;Elghetany MT;Takahashi E;Emile JF;Ferry J;Fogelstrand L;Fontenay M;Germing U;Gujral S;Haferlach T;Harrison C;Hodge JC;Hu S;Jansen JH;Kanagal-Shamanna R;Kantarjian HM;Kratz CP;Li XQ;Lim MS;Loeb K;Loghavi S;Marcogliese A;Meshinchi S;Michaels P;Naresh KN;Natkunam Y;Nejati R;Ott G;Padron E;Patel KP;Patkar N;Picarsic J;Platzbecker U;Roberts I;Schuh A;Sewell W;Siebert R;Tembhare P;Tyner J;Verstovsek S;Wang W;Wood B;Xiao W;Yeung C;Hochhaus A

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.

DOI:10.1038/s41375-022-01629-7

发表时间:2022 Jun 25

作者:von Tresckow J;Cramer P;Robrecht S;Langerbeins P;Fink AM;Al-Sawaf O;Fürstenau M;Illmer T;Klaproth H;Tausch E;Ritgen M;Fischer K;Wendtner CM;Kreuzer KA;Stilgenbauer S;Böttcher S;Eichhorst BF;Hallek M

Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

DOI:10.1038/s41375-022-01630-0

发表时间:2022 Jun 27

作者:Kongkiatkamon S;Terkawi L;Guan Y;Adema V;Hasipek M;Dombrovski T;Co M;Walter W;Awada H;Parker Y;Hutter S;Pagliuca S;Gurnari C;Rogers HJ;Meggendorfer M;Lindner DJ;Haferlach T;Visconte V;LaFramboise T;Jha BK;Maciejewski JP

公众号